Nyxoah (NYXH) has released an update.
Nyxoah, a medical technology company specializing in treatments for Obstructive Sleep Apnea, will unveil its Q3 2024 financial results on November 6, 2024. Investors and stakeholders can join a webcast discussion hosted by company management to gain insights into the company’s financial performance and strategic progress. Nyxoah’s innovations, like the Genio® system, continue to drive its growth and market presence.
For further insights into NYXH stock, check out TipRanks’ Stock Analysis page.
